Cargando…
An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled trial (AARDVARK)
AIMS: The AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition on RisK) trial investigated whether ACE-inhibition reduces small abdominal aortic aneurysms (AAA) growth rate, independent of blood pressure (BP) lowering. METHODS AND RESULTS: A three-arm, multi-centre, single-bli...
Autores principales: | Bicknell, Colin D., Kiru, Gaia, Falaschetti, Emanuela, Powell, Janet T., Poulter, Neil R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5181384/ https://www.ncbi.nlm.nih.gov/pubmed/27371719 http://dx.doi.org/10.1093/eurheartj/ehw257 |
Ejemplares similares
-
Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms
por: Xu, Baohui, et al.
Publicado: (2021) -
Sex-specific differences in the standard of care for infrarenal abdominal aortic aneurysm repair, and risk of major adverse cardiovascular events and death
por: Pouncey, Anna L, et al.
Publicado: (2023) -
Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers increases the risk of postoperative acute kidney injury after elective endovascular abdominal aortic aneurysm repair
por: Xiang, Yuwei, et al.
Publicado: (2022) -
Serum angiotensin-converting enzyme 2 is an independent risk factor for in-hospital mortality following open surgical repair of ruptured abdominal aortic aneurysm
por: Nie, Wanpin, et al.
Publicado: (2016) -
Conserving diggers: from gold miners to aardvarks
por: Mitchell, Duncan
Publicado: (2018)